Professional Documents
Culture Documents
1.2. Autoregulation - CBF constant between MAPs 60-160 mmHg - MAPs > 160 mmHg disrupt BBB - MAPs shift to the right in patient with chronic arterial hipertension - Cerebral autoregulation: miogenic and metabolic mechanism arterial tone tissue metabolitest ( H+, NO, adenosine, prostaglandins,and ionic concentration gradients) vasodilatation and increases flow
1.3. Extrinsic mechanism a. PaCO2 (particularly) - CBF directly proportionate to PaCO2 20-80 mmHg - CBF changes 1-2 ml/100g/min per mmHg change PaCO2 - Hyperventilation (PaCO2 < 20 mmHg ): shift to the left the oxygen Hb dissociation curve. - Cerebral blood volume (CBV) 0.05ml/100gr/min of brain per 1 mmHg in PaCO2
8
b. PaO2 - Hiperoxia : associated minimal CBF (-10%) - Severe hipoxemia PaO2 < 50 mmHg : CBF
c. Temperature - CBF changes 5 - 7% per 1C change temperature - Hypothermia CMR and CBF - If the temperature the brain falls 10C the CMR 50% - If the temperature the brain increases 10C the CMR doubles
10
d. Viscosity - The most important determinant blood viscosity is hematocrit - The optimal cerebral oxygen delivery occur at hematocrit 30%
11
e. Autonomic Influences - Intracranial vessels are innervated by sympathetic (vasoconstrictive) , parasympathetic (vasodilatory), and non-cholinergic non adrenergic fiber, serotonin and vasoactiv intestinal peptide
12
13
support neuronal electrical activity CMR for oxygen consumption (CMR 02) 3 - 3,8 ml/100gr/min CMR for glucose consumption is 5 mg/100gr/min, > 90% is metabolized aerobically During starvation : ketone bodies become major energy substrates Acute hypoglicemia hypoxia Hyperglycemia global and focal hypoxic cerebral acidosis & cellular injury
150ml, formed : a. >> choroid plexuses of the cerebral lateral ventricles active secretion of Na+ b. smaller by the ventricle ependymal cell linings - isotonic fluid, lower : K+, HCO3-, glucose concentration - Decreases production: acetazolamide, corticosteroids, spironolactone, furosemide, isoflurane, and vasoconstrictors - Absorption: translocation fluid from arachnoid 14 granulations cerebral venous sinuses
and CSF 8% Normal pressure 10 mmHg Major compensatory mechanism to rises ICP : a. Displacement CSF from cranial to the spinal compartment b. CSF absorpstion c. CSF production d. Cerebral blood volume (CBV)
15
The initial management increases ICP. Maintaining cerebral O2 delivery with : a. Supplemental O2 b. Elevation of head c. Intubation d. Hyperventilation e. Limitation excees free water and vol resusc. 16
substances (such as most anesthetics) Penetrates poorly: most ions, proteins, and large substances such as mannitol Disrupted by : severe-hypertension, tumors, trauma, strokes, infections, marked hypercapnia, hypoxia, and sustained seizure activity
18
dose dependent
B. INTRAVENOUS AGENTS
- Reduce CMR and CBF (ex. of ketamine)
a. Barbiturates Major actions on CNS : - Hypnosis - Depression of CMR - Reduction of CBF : cerebral vascular resistance - Anticonvulsant activity
20
CMR
CBF
CSF Production
CSF Absorption
CBV
ICP
21
Lidocaine
Electroencephalographic Changes during Anesthesia. Activation Inhalational agents (subanesthetic) Barbiturates (small doses) Benzodiazepines (small doses) Etomidate (small doses) Nitrous oxide Depression Inhalation agents (12 MAC) Barbiturates Opioids Propofol Etomidate
Ketamine
Mild hypercapnia Sensory stimulation Hypoxia (early)
Hypocapnia
Marked hypercapnia Hypothermia Hypoxia (late)
c. Benzodiazepin - CBF and CMR but lesser extent than barbiturates and propofol
d. Ketamine - Dilates the cerebral vasculature and
CBF
23
e. Neuromuscular blocking agents (NMBAs) - Lack direct action secondary effect (histamin released cerebral vasodilatation ICP) f. Opioids - Minimal effect on CBF, CMR and ICP, unless PCO2 (respiratory depression)
24
C. ANESTHETIC ADJUNCTS - Lidocaine ( CMR, CBF and ICP ) - Vasopressors ( CBF : normal autoregulation and intact BBB) - Vasodilators ( Cerebral vasodilatation and CBF) - Mannitol (osmotic diuretic)
26